查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1710121

2025年全球心臟肌鈣蛋白市場報告

Cardiac Troponin Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年心臟肌鈣蛋白市場規模將快速成長。到 2029 年，這一數字將成長至 63.2 億美元，複合年成長率為 10.4%。預測期內的成長歸因於與生活方式相關的心血管疾病患病率的上升、醫院心臟病科室的擴大、居家醫療的日益普及、個性化醫療的成長以及對更高效、更具成本效益的診斷解決方案的需求。預測期內的關鍵趨勢包括採用機器學習演算法進行心臟病學數據解釋、擴大心臟肌鈣蛋白在急性冠狀動脈症候群之外的應用、在同時分析生物標記的多重測試方面取得進展、與肌鈣蛋白一起開發新型生物標記以及個性化醫療。

心臟相關疾病的日益流行預計將推動心臟肌鈣蛋白市場的未來成長。這些疾病包括各種影響心臟結構和功能的心血管疾病，例如冠狀動脈疾病、心臟衰竭、心律不整和先天性心臟疾病。導致盛行率上升的因素包括人口老化、久坐的生活方式、不健康的飲食以及肥胖和高血壓發病率的上升。心臟肌鈣蛋白在診斷心臟相關問題中發揮重要作用，因為它們是識別心肌損傷的敏感生物標記物，尤其是在心臟病發作和其他心臟事件期間。例如，根據新加坡移民與關卡局及衛生署發布的《2023年出生及死亡登記報告》，因缺血性心臟疾病死亡的人數為5,302人，較2022年的5,290人略有增加。因此，心臟病患病率的上升預計將推動心臟肌鈣蛋白市場的發展。

心臟肌鈣蛋白市場的關鍵參與企業正專注於開發基於人類血清的品管等新技術，以透過多參數控制來提高高靈敏度肌鈣蛋白測試的準確性和可靠性。此品管方法利用已知肌鈣蛋白濃度的人類血清來檢驗測試性能。例如，2023年5月，美國生物技術研究公司Bio-Rad Laboratories, Inc.推出了專門針對高靈敏度肌鈣蛋白檢測的多參數品管系統Cardiac Advance。這些基於人類血清的液體對照品以 InteliQ 3mL 管、Liquichek 3mL 標準管和 2.5mL 緊湊型管瓶提供。這些產品包括肌鈣蛋白、CK-MB、BNP/proBNP和肌紅蛋白等10種心臟分析物，並與西門子和羅氏檢測平台相容。這些產品在美國、歐洲和部分亞洲市場有售。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場 - 宏觀經濟情景，包括利率、感染疾病、地緣政治、新冠疫情和經濟復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球心臟肌鈣蛋白PESTEL分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球心臟肌鈣蛋白市場：成長率分析
  • 全球心臟肌鈣蛋白市場表現：規模與成長，2019-2024
  • 全球心臟肌鈣蛋白市場預測：規模與成長，2024-2029，2034
  • 全球心臟肌鈣蛋白總目標市場（TAM）

第6章市場區隔

  • 全球心臟肌鈣蛋白市場類型、表現及預測（2019-2024、2024-2029、2034）
  • 肌鈣蛋白I
  • 肌鈣蛋白T
  • 全球心臟肌鈣蛋白市場（依檢測地點、表現及預測）2019-2024、2024-2029、2034
  • 實驗室環境
  • 照護現場檢驗 (POC)
  • 全球心臟肌鈣蛋白市場應用、績效及預測（2019-2024、2024-2029、2034）
  • 急性冠狀動脈症候群
  • 心肌梗塞
  • 鬱血性心臟衰竭衰竭
  • 其他
  • 全球心臟肌鈣蛋白市場（依最終用戶、績效及預測）2019-2024、2024-2029、2034
  • 醫院
  • 診斷中心
  • 居家照護環境
  • 其他
  • 全球心臟肌鈣蛋白市場、肌鈣蛋白 I 細分市場、類型、績效及預測（2019-2024 年、2024-2029 年、2034 年）
  • 心肌肌鈣蛋白I（cTnI）
  • 肌鈣蛋白I
  • 全球心臟肌鈣蛋白市場、肌鈣蛋白 T 細分市場、類型、績效及預測（2019-2024 年、2024-2029 年、2034 年）
  • 心肌肌鈣蛋白T（cTnT）
  • 骨骼肌肌鈣蛋白T

第7章 區域和國家分析

  • 全球心臟肌鈣蛋白市場各地區表現及預測（2019-2024、2024-2029、2034）
  • 全球心臟肌鈣蛋白市場（依國家分類）、績效及預測（2019-2024 年、2024-2029 年、2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 心臟肌鈣蛋白市場：競爭格局
  • 心臟肌鈣蛋白市場：公司簡介
    • F. Hoffmann-La Roche Ltd
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • Merck KGaA
    • Siemens Healthineers AG

第31章 其他大型創新企業

  • Becton Dickinson and Company
  • Laboratory Corporation of America Holdings（Labcorp）
  • Zoetis Inc.
  • bioMerieux SA
  • Beckman Coulter Inc.
  • QuidelOrtho Corporation
  • Sysmex Corporation
  • Bio-Rad Laboratories Inc.
  • Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
  • Radiometer Medical ApS
  • Randox Laboratories Ltd.
  • Fujirebio Diagnostics Inc.
  • Meso Scale Diagnostics LLC.
  • Singulex Inc.
  • Diazyme Laboratories Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第35章：市場潛力大的國家與策略

  • 2029 年心臟肌鈣蛋白市場：提供新機會的國家
  • 2029 年心臟肌鈣蛋白市場：細分市場帶來新機會
  • 2029年心臟肌鈣蛋白市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r31700

Cardiac troponin refers to a set of proteins located in the heart muscle (myocardium) that play a crucial role in regulating heart contractions. These troponins are components of the muscle fiber proteins that manage the interaction between actin and myosin, which are vital for muscle contraction. They serve as biomarkers used for diagnosing heart injuries, particularly in the case of heart attacks.

The primary types of cardiac troponin are troponin I and troponin T. Troponin I is a protein present in heart muscle cells that aids in the regulation of muscle contractions, and increased levels of Troponin I in the bloodstream may indicate heart injury or stress, making it critical for precise cardiac diagnostics. Testing can be conducted in laboratory environments as well as through point-of-care (PoC) testing, applicable in scenarios such as acute coronary syndrome, myocardial infarction, and congestive heart failure, among others. The end users of this testing include hospitals, diagnostic centers, home care settings, and more.

The cardiac troponin market research report is one of a series of new reports from the business research company that provides cardiac troponin market statistics, including cardiac troponin industry global market size, regional shares, competitors with an cardiac troponin market share, detailed cardiac troponin market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac troponin industry. This cardiac troponin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cardiac troponin market size has grown rapidly in recent years. It will grow from $3.85 billion in 2024 to $4.25 billion in 2025 at a compound annual growth rate (CAGR) of 10.6%. The growth in the historic period can be attributed to rising prevalence of cardiovascular diseases, increasing awareness and early diagnosis of heart conditions, expanding healthcare infrastructure in emerging markets, growth in the elderly population, introduction of high-sensitivity cardiac troponin assays.

The cardiac troponin market size is expected to see rapid growth in the next few years. It will grow to $6.32 billion in 2029 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to rising prevalence of lifestyle-related cardiovascular conditions, expansion of cardiac care units in hospitals, increasing adoption of home healthcare, growth in personalized medicine, and demand for more efficient and cost-effective diagnostic solutions. Major trends in the forecast period include adoption of machine learning algorithms for data interpretation in cardiac care, expanding applications of cardiac troponin beyond acute coronary syndrome, advancements in multiplex testing for simultaneous biomarker analysis, development of novel biomarkers alongside troponin, and personalized medicine.

The rising incidence of heart-related diseases is anticipated to drive the growth of the cardiac troponin market in the future. These diseases include various cardiovascular issues such as coronary artery disease, heart failure, arrhythmias, and congenital heart defects, all of which impact the heart's structure and functionality. Factors contributing to this increasing prevalence include aging populations, sedentary lifestyles, unhealthy dietary habits, and escalating rates of obesity and hypertension. Cardiac troponin plays a vital role in diagnosing heart-related issues as it serves as a highly sensitive biomarker for identifying heart muscle damage, especially in the context of heart attacks and other cardiac events. For example, the Report on Registration of Births and Deaths 2023 from Singapore's Immigration and Checkpoints Authority and Ministry of Health indicated that deaths from ischemic heart diseases totaled 5,302, marking a slight rise from 5,290 in 2022. Thus, the growing prevalence of heart conditions is expected to boost the cardiac troponin market.

Key players in the cardiac troponin market are concentrating on developing new technologies, such as human serum-based quality control, to enhance the accuracy and reliability of high-sensitivity troponin testing through multi-analyte controls. This quality control approach utilizes human serum with known troponin levels to validate assay performance. For instance, in May 2023, Bio-Rad Laboratories, Inc., a biotechnology research firm based in the U.S., launched Cardiac Advance, a multi-analyte quality control system specifically tailored for high-sensitivity troponin testing. These liquid, human-serum-based controls are provided in InteliQ 3-mL tubes, Liquichek 3-mL standards, and 2.5-mL compact vials. They include 10 cardiac analytes, such as troponin, CK-MB, BNP/proBNP, and myoglobin, and are compatible with testing platforms from Siemens and Roche. These products are available in the U.S., Europe, and select Asian markets.

In February 2022, Prolight Diagnostics AB, a Swedish medical equipment manufacturer, acquired Psyros Diagnostics Ltd. for $5.78 million. This acquisition aims to integrate Psyros Diagnostics' advanced single-molecule counting technology into Prolight Diagnostics' offerings, resulting in the development of highly sensitive, rapid, and cost-effective point-of-care (POC) testing solutions. This move enhances their capabilities across various clinical areas and solidifies their presence in the POC market. Psyros Diagnostics Ltd., a UK-based company, has created the Psyros POC system, a device designed to measure the cardiac troponin biomarker.

Major companies operating in the cardiac troponin market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Siemens Healthineers AG, Becton Dickinson and Company, Laboratory Corporation of America Holdings (Labcorp), Zoetis Inc., bioMerieux SA, Beckman Coulter Inc., QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Radiometer Medical ApS, Randox Laboratories Ltd., Fujirebio Diagnostics Inc., Meso Scale Diagnostics LLC., Singulex Inc., Diazyme Laboratories Inc., Response Biomedical Corporation, Eurolyser Diagnostica GmbH, LifeSign LLC

North America was the largest region in the cardiac troponin market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac troponin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cardiac troponin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cardiac troponin market consists of sales of diagnostic assays, test kits, point-of-care testing devices, and high-sensitivity troponin tests. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cardiac Troponin Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cardiac troponin market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cardiac troponin ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cardiac troponin market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Troponin I; Troponin T
  • 2) By Location Of Testing: Laboratory Setting; Point Of Care (Poc) Testing
  • 3) By Application: Acute Coronary Syndrome; Myocardial Infraction; Congestive Heart Failure; Other Applications
  • 4) By End User: Hospitals; Diagnostic Centers; Homecare Setting; Other End Users
  • Subsegments:
  • 1) By Troponin I: Cardiac Troponin I (cTnI); Muscle Troponin I
  • 2) By Troponin T: Cardiac Troponin T (cTnT); Skeletal Troponin T
  • Companies Mentioned: F. Hoffmann-La Roche Ltd; Thermo Fisher Scientific Inc.; Abbott Laboratories; Merck KGaA; Siemens Healthineers AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cardiac Troponin Market Characteristics

3. Cardiac Troponin Market Trends And Strategies

4. Cardiac Troponin Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Cardiac Troponin Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Cardiac Troponin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Cardiac Troponin Market Growth Rate Analysis
  • 5.4. Global Cardiac Troponin Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Cardiac Troponin Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Cardiac Troponin Total Addressable Market (TAM)

6. Cardiac Troponin Market Segmentation

  • 6.1. Global Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Troponin I
  • Troponin T
  • 6.2. Global Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Laboratory Setting
  • Point Of Care (Poc) Testing
  • 6.3. Global Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Acute Coronary Syndrome
  • Myocardial Infraction
  • Congestive Heart Failure
  • Other Applications
  • 6.4. Global Cardiac Troponin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Diagnostic Centres
  • Homecare Setting
  • Other End Users
  • 6.5. Global Cardiac Troponin Market, Sub-Segmentation Of Troponin I, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiac Troponin I (cTnI)
  • Muscle Troponin I
  • 6.6. Global Cardiac Troponin Market, Sub-Segmentation Of Troponin T, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiac Troponin T (cTnT)
  • Skeletal Troponin T

7. Cardiac Troponin Market Regional And Country Analysis

  • 7.1. Global Cardiac Troponin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Cardiac Troponin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cardiac Troponin Market

  • 8.1. Asia-Pacific Cardiac Troponin Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cardiac Troponin Market

  • 9.1. China Cardiac Troponin Market Overview
  • 9.2. China Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cardiac Troponin Market

  • 10.1. India Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cardiac Troponin Market

  • 11.1. Japan Cardiac Troponin Market Overview
  • 11.2. Japan Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cardiac Troponin Market

  • 12.1. Australia Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cardiac Troponin Market

  • 13.1. Indonesia Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cardiac Troponin Market

  • 14.1. South Korea Cardiac Troponin Market Overview
  • 14.2. South Korea Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cardiac Troponin Market

  • 15.1. Western Europe Cardiac Troponin Market Overview
  • 15.2. Western Europe Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cardiac Troponin Market

  • 16.1. UK Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cardiac Troponin Market

  • 17.1. Germany Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cardiac Troponin Market

  • 18.1. France Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cardiac Troponin Market

  • 19.1. Italy Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cardiac Troponin Market

  • 20.1. Spain Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cardiac Troponin Market

  • 21.1. Eastern Europe Cardiac Troponin Market Overview
  • 21.2. Eastern Europe Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cardiac Troponin Market

  • 22.1. Russia Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cardiac Troponin Market

  • 23.1. North America Cardiac Troponin Market Overview
  • 23.2. North America Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cardiac Troponin Market

  • 24.1. USA Cardiac Troponin Market Overview
  • 24.2. USA Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cardiac Troponin Market

  • 25.1. Canada Cardiac Troponin Market Overview
  • 25.2. Canada Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cardiac Troponin Market

  • 26.1. South America Cardiac Troponin Market Overview
  • 26.2. South America Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cardiac Troponin Market

  • 27.1. Brazil Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cardiac Troponin Market

  • 28.1. Middle East Cardiac Troponin Market Overview
  • 28.2. Middle East Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cardiac Troponin Market

  • 29.1. Africa Cardiac Troponin Market Overview
  • 29.2. Africa Cardiac Troponin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Cardiac Troponin Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Cardiac Troponin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cardiac Troponin Market Competitive Landscape And Company Profiles

  • 30.1. Cardiac Troponin Market Competitive Landscape
  • 30.2. Cardiac Troponin Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

31. Cardiac Troponin Market Other Major And Innovative Companies

  • 31.1. Becton Dickinson and Company
  • 31.2. Laboratory Corporation of America Holdings (Labcorp)
  • 31.3. Zoetis Inc.
  • 31.4. bioMerieux SA
  • 31.5. Beckman Coulter Inc.
  • 31.6. QuidelOrtho Corporation
  • 31.7. Sysmex Corporation
  • 31.8. Bio-Rad Laboratories Inc.
  • 31.9. Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
  • 31.10. Radiometer Medical ApS
  • 31.11. Randox Laboratories Ltd.
  • 31.12. Fujirebio Diagnostics Inc.
  • 31.13. Meso Scale Diagnostics LLC.
  • 31.14. Singulex Inc.
  • 31.15. Diazyme Laboratories Inc.

32. Global Cardiac Troponin Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cardiac Troponin Market

34. Recent Developments In The Cardiac Troponin Market

35. Cardiac Troponin Market High Potential Countries, Segments and Strategies

  • 35.1 Cardiac Troponin Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Cardiac Troponin Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Cardiac Troponin Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer